Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ADONIS-PCI
2020-004887-24Phase 3Active
- Sponsor
- Medical University of Gdańsk
- Start
- Jan 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of ticagrelor and dabigatran in acute coronary syndrome (ACS) and Atrial fibrillation (AFib), sponsored by Medical University of Gdańsk. Started Jan 2021; status: active.
02
Drugs
ticagrelordabigatran
03
Conditions
acute coronary syndrome (ACS)Atrial fibrillation (AFib)
Beyond the preview
Go deeper on 2020-004887-24.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2020-004887-24.